Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Mark Brister > Profile

Mark Brister

Affiliations

  • Chief Technology Officer at Obalon Therapeutics Inc (OBLN), 2020-01-28
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OBLN $4.00 5,000 $20,000.00 38,865 2019-08-06 Filing